Skip to main content
Loading

Yinuoke

October 17, 2023
Franciscan C
Oncology
Company Description: Yinuoke is a biotech company developing First-in-Concept therapies for cancer patients who have exhausted available therapies based on a deep and unique understanding of cancer biology and immunology. We are developing a pipeline with multiple innovative therapeutic products aiming to reshape the care of terminal cancer.
Speakers
Lingbing Zhang, CEO - Yinuoke

Country

China

Website

http://under development

CEO/Top Company Official

CEO

Lead Product in Development

YNK105: small molecule drug for cancer cachexia; IND-enabling YH101: FIC antibody drug for cancer and cancer cachexia: IND-enabling

Development Phase of Primary Product

Pre-Clinical

Number Of Unlicensed Products

2

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS